Your session is about to expire
← Back to Search
Behavioural Intervention
UC-A for Attention Deficit Hyperactivity Disorder (ADHD)
N/A
Recruiting
Led By Robert Bilder, Ph.D
Research Sponsored by Think Now Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Able to use a keyboard with both hands
Participant is aged 18-50 years at time of consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (day 0) and midpoint (day 25), and baseline (day 0) and endpoint (day 50)
Awards & highlights
Study Summary
"This trial aims to see if using mobile apps can help improve cognitive function and reduce symptoms in adults with ADHD."
Who is the study for?
This trial is for adults who have been diagnosed with ADHD. The specific eligibility criteria are not provided, so it's important to contact the study organizers for detailed information on who can participate.Check my eligibility
What is being tested?
The trial is testing two mobile app digital therapies, referred to as UC-A and UC-N, to see how they affect cognitive function and symptoms in adults with ADHD.See study design
What are the potential side effects?
Since the interventions are mobile apps designed for therapeutic purposes, side effects may be minimal but could include eye strain or headache from screen use. Specific side effects will depend on the nature of the app activities.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can use a keyboard with both hands.
Select...
I am between 18 and 50 years old.
Select...
My vision and hearing are normal, or corrected to be normal.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (day 0) and midpoint (day 25), and baseline (day 0) and endpoint (day 50)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (day 0) and midpoint (day 25), and baseline (day 0) and endpoint (day 50)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Conners Continuous Performance Task (CPT3) - HRT Std (Change from Baseline to Midpoint Mid-treatment, and Baseline to Endpoint Post-treatment)
Secondary outcome measures
Barkley Adult ADHD Rating Scale (BAARS-IV) - Inattentive Subscale (Inatt). (Change from Baseline to Midpoint Mid-treatment, and Baseline to Endpoint Post-treatment)
Nelson Denny Reading Comprehension Test (NDRT) - Reading Comprehension Scaled Score (Change from Baseline to Midpoint Mid-treatment, and Baseline to Endpoint Post-treatment)
Other outcome measures
Adult ADHD Quality of Life Scale (AAQoL) - Productivity. (Change from Baseline to Midpoint Mid-treatment, and Baseline to Endpoint Post-treatment)
Trial Design
2Treatment groups
Active Control
Group I: UC-AActive Control1 Intervention
UC-0A is a digital mobile app intervention that uses cognitive control skills for task performance. The intervention is used once a day, 5 days a week, for 7 weeks.
Group II: UC-NActive Control1 Intervention
UC-0N is a digital mobile app intervention that uses cog control skills for problem solving. The intervention is used once a day, 5 days a week, for 7 weeks.
Find a Location
Who is running the clinical trial?
University of California, Los AngelesOTHER
1,532 Previous Clinical Trials
10,265,128 Total Patients Enrolled
10 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
976 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Think Now IncorporatedLead Sponsor
3 Previous Clinical Trials
445 Total Patients Enrolled
3 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
445 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
University of California, BerkeleyOTHER
181 Previous Clinical Trials
721,016 Total Patients Enrolled
2 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
457 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Which individuals meet the necessary qualifications to participate in this clinical trial?
"Those eligible to participate in this research must have attention deficit hyperactivity disorder (ADHD) and fall between the ages of 18 and 50. The trial has availability for a maximum of 140 participants."
Answered by AI
What is the current number of subjects participating in this medical research study?
"Affirmative. The details available on clinicaltrials.gov indicate that this investigation is presently enrolling volunteers. It was first made public on January 3rd, 2024 and underwent the most recent update on February 4th, 2024. This research initiative aims to recruit a total of 140 individuals from two distinct sites."
Answered by AI
Are there any available vacancies for potential participants in this research study?
"As per clinicaltrials.gov, this investigation is presently seeking participants. The trial was initially listed on 1/3/2024 and last modified on 2/4/2024."
Answered by AI
Is the clinical trial inclusive of individuals younger than 70 years old?
"Patients aged between 18 and 50 years are eligible for participation in this research. There are a total of 118 trials available for individuals under 18 years old, and 36 studies catering to the elderly population over 65 years old."
Answered by AI
Who else is applying?
What site did they apply to?
University of California Berkeley
What portion of applicants met pre-screening criteria?
Met criteria
Why did patients apply to this trial?
Hoping for breakthrough medical solution. I have tried a lot of methods of helping my ADHD and many apps. I am looking for something that works well & consistently.
PatientReceived no prior treatments
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger